Elk to squeeze Nebraskan oil field with Enhanced Oil Recovery method

Published 23-APR-2014 11:03 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Elk Petroleum Ltd (ASX: ELK) has acquired a large section of the Singleton Oil Field in Nebraska where it plans to tap the area’s remaining reserves using CO2 enhanced oil recovery (EOR) techniques.

Singleton Oil Field

The Singleton Oil Field has historically produced 10.9M barrels of oil, making it the largest oil field in the Panhandle of Nebraska.

ELK has carried out reservoir engineering studies that show a CO2-EOR project will have the potential to recover a further two to four million barrels of oil from an area known as The Singleton Unit.

ELK also has a water source in a well that will provide the site’s water injection which is needed for the CO2-EOR project.

Singleton Unit acquisition

The transaction date for the acquisition of The Singleton Unit has been set for 1 May 2014 and under the agreement ELK also has until the end of this year to decide whether it would like to purchase the adjoining Singleton Heirs well and lease the southeast of the Singleton Unit.

ELK plans to take CO2 from the Bridgeport Ethanol LLC plant, which is situated 40km from the Singleton Unit, and use this to recover any remaining oil in the Singleton Oil Field.

ELK has a purchase agreement with Bridgeport Ethanol entitling them to buy all of the CO2 fermentation emissions from the ethanol plant for the next 10 years.

The company is also processing a purchase of a CO2 pipeline that will run from the Bridgeport Ethanol plant to the Singleton Oil Field.

“The Bridgeport-Singleton project will be producing low-carbon-intensity oil, due to the biogenic source of the CO2 and this oil can be sold at a premium price into the California market,” says Scott Hornafius, ELK’s Chief Executive.

Further funding for Singleton project

ELK hopes to attract green energy funding for development of the site, as these funders have a mandate to develop energy that has lower CO2 emissions than conventional developments. The project will use a corn-ethanol source for its CO2, making the CO2-EOR process a carbon negative project.

A number of green energy funds in the US are being approached by ELK to offer the chance of funding the development.

tags

OIL


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X